chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered pharmacist concerning a 63 year old female patient with cancer in remission and no drug reactions or allergies who on 22-JUN-2012 was vaccinated subcutaneously with 0.65 ml dose of ZOSTAVAX (Merck) (lot# 671786/0254AE; expiration date 08-MAR-2013). In June 2012, the patient developed injection site reaction of erythema, inflammation and warmth. The area was about 6 inches long on the patient's arm. The pharmacist said there was no rash. The patient sought unspecified medical attention in the pharmacy. No laboratory diagnostic studies were performed. At the time of the report, the patient had not recovered. Additional information has been requested.
I was suffering from allergies and it developed into a sinus and ear infection starting on 6/17 and coming severe on Saturday and that is the day I went to the Urgent Care. They prescribed me Amoxytaz antibiotic. That helped with my symptoms.
2 inch wide raised red area surrounding injection site. It is painful, and hot to touch. This has happened every time he has received a flu shot. It will last for days.
pt stated that she had a sore arm and low grade fever the night after receiving the 2nd dose of the covid vax. She started having vision problems about an hour after receiving the vaccination.  She stated that her vision is blurry and she has to blink a lot so she can see anything.  Today 3/5/2021 the only symptom she is having blurred vision.  Pt will contact her PCP if her symptoms persist.
Initial report received on 13 November 2008 from a health care professional. A 48-year-old male patient, who had no concurrent illnesses or pre-existing conditions, and who had no known allergies, had received a 0.5 mL intramuscular injection of Fluzone SV 2008-200 (lot number U2741AA) on 01 November 2008. Approximately 24 hours later, on 02 November 2008, the patient experienced a temperature of 102.0 degrees Fahrenheit, aches, weakness, fatigue and heart palpitations. The heart palpitations lasted five days. The reporter did not know any other details, or if the patient was evaluated by a physician. It was "unknown" if any diagnostic tests or laboratory data were performed or collected. At the time of this report, the patient's recovery status was "unknown." Follow-up information received 04 February 2009 from a health care professional who reviewed the case, and had no additional information to provide at this time. Documents held by sender: None
Covid vaccine was given to individual with being diluted.  Vitals being taken after shot given, WNL.  Dr.  was notified and he suggested to wait in waiting room for two hours for monitoring.  At this point, 45 minutes after administration, no reaction.  No SOB, no swelling, no cough, no rash or any other adverse reaction.
This case was reported by a other health professional via call center representative and described the occurrence of erythema urticarial in a 75-year-old male patient who received SHINGRIX for prophylaxis. On 3rd July 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In July 2018, 2 days after receiving SHINGRIX, the patient experienced erythema urticarial and eye swelling. In July 2018, the outcome of the erythema urticarial and eye swelling were recovered/resolved. It was unknown if the reporter considered the erythema urticarial and eye swelling to be related to SHINGRIX. Additional details were provided as follows: The pharmacy student reported that one of their patients received the SHINGRIX vaccine. Two days after the patient complained about red welts on his legs and swollen eyes. The patient recovered after 6 days. The reporter's call was transferred to medical information.
Nausea, fever, pain, hypotension, malaise, arthralgia; onset of Sx's 8:00 a.m. on 3/27/03; treated with IV fluids, phenergan IV 50 mg for vomiting. Observation.
I received laryngitis and severe tiredness for about 4 days and I took an antiviral unknown and felt better.
Pt called next day c/o headache, fever 100.8,,"not feeling well"  beginning eveing after injection.
Pfizer-BioNTech COVID- 19 Vaccine EUA: Vaccine recipient  failed to answer screening questions truthfully, when asked if she had received a vaccine anywhere else, she responded no. Pt was given her "first dose" of Pfizer by vaccinator. When vaccinator gave patient a vaccine card with Pfizer sticker on it, the patient pulled out a vaccine card that already had one dose of Moderna given on 3/2/2021 by another site. Patient interviewed and stated that she didn't realize it mattered which brand she received and when asked why she answered the question about previous vaccine, she said she just wanted to finish her vaccine series up and knew we wouldn't give her the vaccine if she told the truth.
I am submitting this form because of wrong administration of vaccine. I have pictures of how my vaccine was given. The needle went in at between a 10 and 15 degree slant. It was injected just under the skin. I also am questioning the type of syringe and needle used. Possibly an insulin syringe. I would also like to add that when they withdrew the needle from my arm I watched the person finish pushing  the plunger and vaccine expelled into the air.  Next day I had some redness around the injection site. Some soreness.  My question is do I need a repeat 1st dose?  I have pictures of just before the injection and during the injection. Just need to know where to send them.
Pt was here for influenza vaccine, given DTAP that was intended for sibling at the same visit. 10/28 pt was here for Influenza vaccine, given DTAP that was intended for sibling at the same visit. 10/29-phone call to mother, child had stomach ache no vomiting no fever. 10/30-phone call to mom-fever last night, tactile, resolved this AM.
Hair thinning and severe dermatitis, redness, burning,  and shedding of scalp. Eventually had to be medically treated.
Patient was vaccinated on 7/30/07 with DTap and Proquad.  She began with a rash and fever on 8/6/07.  Fever up to 102 and 103.  She ran fever off and on until 8/10/07, with the rash continuing to spread today.  Returned to clinic 8/13/07 and diagnosed with Morbilliform rash after administration of Proquad.  Epinephrine 0.08ml given SubQ at 1510 and a prescription for oral prednisone to be given at home.
Numbness Tremor in hands   1 to 5 times daily contacted PCP spoke with nurse and was told that she hadn't heard of this  reaction to the vaccine, and we could come in and talk with the Dr. but no other recommendations.
I got the shot around 3:30PM, I had a very slight headache so I took aspirin around 8:00PM to avoid it from getting worse. Other than that I felt fine, the only strange effect was later as I went to bed around 11:30PM and work up around 1:30AM to use the restroom and that is when I notice that my eye vision was blurry. I went to the microwave digital clock and could not make out the numbers at all. I was up for an hour or so and my vision was coming and going while looking at the computer screen. I called the local hospital to report the vision issue, they just advise that I could come in to get it checked out. I just decided to just go back to bed and see how it is in the morning, I got up around 6:00AM and my vision was back to normal and has been to date. I just want to report it, nervous about 2nd dose as I do not read this as a side affect for the Moderna shot. I did read that it is rare for the shot. I reported to pharmacy. Thank You.
flu-like sx w/h/a, nausea & diarrhea, aches & pains in back & arms, dry mouth;wanted to know if could be getting rabies & concerned about receiving last dose;scratched by a raccoon on 29MAY95 & recv tx;
Patient experienced headache, fatigue, from injection site down to the elbow was "bright red".
transferred to this hospital from outside hospital with GI bleed; hematemesis; intubated due to worsening respiratory failure; cardiac arrest twice post intubation; positive for COVID; severely acidotic; pupils dilated and fixed; shock worsening; DNR; pt passed away in the hospital
I had headache and tired 3 days. Leg pains and chills, tired lasted all lasted 5 hours.  MRi swollen lymph note under left breast  in September 26th , 2021.   2-Clump non mass enhancement in left breast . Also found other issues pending my biopsy
It was reported in a published article, that a 24 month old HIV negative male, whose mother is HIV positive, was vaccinated per protocol with a first dose of MMR II at 6 months of age. It was reported that as per the protocol, he received a second dose of MMR II at 18 months of age. He regressed into autism around 24 months of age. The author noted that "vaccination can be frequently associated with early onset autism." It was also reported that "in spite of its limitations, this study suggests that an autism/vaccine connection may exist." Upon internal review, autism was considered to be an important medical event (OMIC). It was unknown if medical attention was sought.
Anaphylaxis to yellow fever vaccine-tachycardia, wheezing, respiratory distress, hypoxemia of 87 % on RA, dropharyngeal edema, diaphoresis, anxiety. Treated with three doses of 0.3mg epinephrine, 1 dose of IVS dumedrol 125mg, and 25mg Benadryl IV. Transferred to ER.
11/29/21 presents to ED for "confusion over the last 2-3 days ". PMHx of "metastatic small cell lung cancer w/ brain mets s/p parietal craniotomy for mass resection"
Pt began having myoclonic seizures within 2-3 days after the shot and had several Tonic Clonics June 17, 2008. Was admitted to hospital. Continues to have seizures daily and has been diagnosed with Epilepsy (Doose Syndrome.) Takes 2 kinds of medication 2x daily and will continue for the next 2 yrs. Keppra (5ml)and Lamictal (37mg).  3/16/09 Received ER medical records of 6/17/2008. FINAL DX: afebrile seizure, strep throat Records reveal patient experienced generalized seizure x approx 1 min w/unresponsivelness, stiffness, twitching of extremities, eyes roll up, lips cyanotic, postictal afterward w/O2 sat of 85% when EMS arrived.  In ER patient c/o sore throat & HA.  Referred for outpatient EEG & if abnormal referral to Neuro.  D/C home on oral antibiotics & no antiseizure meds unless repeat seizure.   3/23/09 Received hospital medical records of 6/17-6/18/2009. FINAL DX: new onset seizures; streptococcal pharyngitis Records reveal patient experienced additional witnessed tonic-clonic seizure at home lasting approx 2 min followed by postictal period s/p ER visit for same earlier that day.  Neuro consult done.  Started on antiseizure meds & continued oral antibiotics, d/c to home w/Neuro & MRI f/u. 1/27/2010 Still take medication for epileepsy, however, he has not had a seizure since 05/23/09, which is exactly a year to the day he had the Hep A shot.
Narrative:  74 yo M with hx of angina, HLD, dementia, BPH, CAD with lv stent placed in 1990, COPD, CKD, and OA received 1 dose of Pfizer vaccine on 01/14/2021.Pt died on 8/14/2021. Death is not likely due to vaccinations due to other comorbidities and time from vaccination.
Swollen upper lip, edema and redness at injection site. 6X10 cus. A follow up report received 11/01/2001 adds: Reporter gave additional time line info; pt seen at local ER on 10/14/01 where she was given Decadron and Depomedrol; she was checked in the office on the 15th with some improvement. Office personnel saw her in passing today and she looks well.
Patient received 4 yr. old vaccines on 07-17-17. Patient came in 07-19-17 because the left thigh had large 10 cm diameter local reaction to the PROQUAD vaccine. It was slightly warm, erythematous and slightly swollen with a small bruise centrally. No pain.
redness of injection site; arm aches; itching around injection site; Swelling around injection site; This is a spontaneous report from a contactable consumer reporting for herself. A non-pregnant 76-years-old female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, administered  via an unspecified route in right arm on 10Mar2021 13:30, at 76 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included hypertension, kidney disease, stroke survivor, breast cancer survivor and allergy to nichel and to shrimp, all from an unknown date. Historical vaccine included the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, administered via an unspecified route in right arm on 17Feb2021 13:30 , at 76 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Concomitant medications included allopurinol, metoprolol, atorvastatin, lisinopril and rivaroxaban (XAREL), all taken for an unspecified indication, since an unspecified date. The patient didn't receive any other vaccine in the previous 4 weeks. She was not diagnosed with COVID-19 prior to vaccination and was not tested positive for COVID-19 post vaccination. On 11Mar2021 08:00 the patient experienced redness of injection site, arm aches, itching around injection site and swelling around injection site. No treatment was received for the events. At the time of the report the events had not resolved yet.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient came in about 1.5 hours after vaccine stating there was a rash on his back/torso. Patient took oral benadryl  for the rash.  Parents decided to go to the ER just incase to make sure the patient was okay.  Per Father the next day the he reported that by the time they got to the ER the rash was over 50% gone. The ER recommended Zyrtec and benadryl if needed later and said it was correct patient took the first does of Benadryl at onset of symptoms as directed.  Patient is fine today and per father didn't need any additional benadryl.
Significant local swelling, erythema, induration, AS WELL AS MULTIPLE VESICLES all within a 5cm diameter around the vaccine site.  Benadryl was given by mouth, with improvement.
woke up on friday AM w/some hives;cont to devel hives all day;were pretty much gone by Saturday afternoon;on Saturday Am woke up w/shoulder & joint ache, going up lt side of neck;achiness about the same now;took advil all weekend;
did not give consent to follow-up. This spontaneous report was received from a nurse referring to unspecified number of patents of unknown age and gender. No information regarding patients' medical history, concurrent conditions and concomitant medications were provided. On an unknown dates starting on or after 02-JUL-2016, the patients were vaccinated with improperly stored doses of PEDVAXHIB (dose, route, lot # and expiry date not reported). The vaccine was exposed to temperature of 32.4 degree Fahrenheit for 95 hour. No previous temperature excursion and no adverse effects were reported. The call was not due to data logger. This is one of several reports received from the same reporter. Additional information has been requested
Subject, a 23 year old female with a history of polycystic ovarian disease, received the 2nd dose of Anthrax vaccine on 14Nov2001. No other vaccinations were given on that date. The pt was taking birth control medication for contraception and polycystic ovarian disease.  The pt received the first dose of Anthrax vaccine on 31Oct01 with no adverse reaction. On 14Nov, one hour after injection, the pt experienced mild dizziness. The dizziness became severe for five minutes on 16Nov01 when the pt moved her head while in sitting position. On 17Nov2001, the dizziness returned when the pt got out of bed. The dizziness continued for most of the day, worsening with activity, and was accompanied by nausea. The pt experienced less dizziness on 18Nov01 with two episodes occurring during activity that lasted five minutes each. As of 19Nov01, the symptoms had resolved.
This case has been migrated from another database into the current safety database for processing follow-up information. As a consequence of this migration, the follow-up CIOMS I or MedWatch report may indicate in the appropriate field that it is an initial report. New information was received in test results, event outcome and medical monitor comments. Information regarding Pneumococcal Conjugate Vaccine, 13-Valent (injection) was received from an investigator regarding an 83-year-old male participant in a study who experienced idiopathic thrombocytopenic purpura. The participant received the second dose on 03-Apr-2009. The patient experienced idiopathic thrombocytopenic purpura on 13-Aug-2009. The patient was hospitalized and diagnostic tests were performed (see test results). The patient was treated with steroids and IVIG for 5 days. The platelet count improved and the patient was discharged on 20-Aug-2009. The patient was re-admitted to the hospital on 26-Aug-2009 with symptoms of epistaxis, buccal bruising, petechiae on lower extremities, and a low platelet count of 5000. He was treated with RITUXAN and methylprednisolone. Idiopathic thrombocytopenic purpura (ITP) was considered resolved on 20-Nov-2009. The investigator does not consider that concomitant medications taken prior to this SAE were related to the development of ITP. No additional information was available at the time of this report. The investigator does not consider mild renal failure to have prolonged hospitalization. This is a final report. The investigator considered idiopathic thrombocytopenic purpura possibly related to the study product. The medical monitor considered idiopathic thrombocytopenic purpura not related to the study product. The medical monitor noted that the last dose of any vaccine was 4 months prior to the signs and symptoms of ITP. The subject had serologic evidence of Hepatitis B infection, though onset has not yet been established. Follow-up (24Mar16): This follow up is submitted to notify that the history of the patient has also been published in the literature report. No further information provided.
Patient is deceased. Family called the pharmacy on 2-17-21 to let us know he would not be coming for his second appointment. When the pharmacist tried to call the family back for more info, the phone number on file doesn't work.
right arm at site of injection bleed and then swelled within 2 minutes of vaccination of pneumovax.
This spontaneous report was received from a medical assistant refers to a three number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with PROQUAD (dose, and route were not reported) that were improperly stored. No adverse events were reported. This is one of several reports from the same source. Additional information has been requested.
Both doses given 4/22/21 and 5/20/21 before the age of 18.
Bumps all over body. Low Fever, Fussy all started a week after injection. Bumps started on back and spread to other parts of stomach, legs, and arms.
L arm pain started after vaccine, resolved and then restarted a week later affecting sleep exacerbated by pressure in area
Projectile vomiting, explosive diarrhea, extreme nausea, diaphoresis, weakness beginning approx. 6 hrs after flu shot into next day. Developed severe cough, congestion with continued weakness and fatigue. Worsening symptoms 11/23-11/26 with nausea, vomiting, diarrhea and abd. cramping. Seen by ER 11/26 with dx. gastroenteritis with N, V, D and mild dehy. 11/30/04 acute renal failure. Put on Dialysis. Developed CHF. The discharge summary received on 3/23/04 states acute tubular necrosis, interstitial nephritis and anemia.
This is a spontaneous report from a contactable healthcare professional via a Pfizer sales representative. An 18-year-old female patient received TRUMENBA, lot number: S56024, expiration date 28Feb2019, via an unspecified route of administration on 07Sep2018 at single dose for immunisation. The patient medical history was not reported. Concomitant medication included SYMBICORT. The patient experienced described her symptoms as similar to a cold, her arm was hot and allergic reaction on an unspecified date. The outcome of the event was unknown.
Red hives @ reaction sites within hours of vaccination, diffuse hives without airway involvement within 24 hr. subsequent intermittent hives w/ possible egg in diet association.
Blisters to nose and mouth. Severe joint pain to the point of weakness with inability to complete usual ADLs. Dizziness. Severe fatigue (slept 24 hours)
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient rec'd Pfizer Vaccines on 2/3/2021 and 2/24/2021. PMHx of cirrhosis, COPD, CAD w/stent, osteoarthritis sepsis and repiratory failure requiring tracheostomy in the past. Presented to ED one week ago c/o SOB. COVID negative, s/p bronchoscopy on 11/12, tx'd w/abx, d/c'd home on O2 via NC. Per pt. 2nd Covid test + prior to d/c. Presented to ED on 11/17 w/SPO2 in the 30s on NC. Admitted for ACRF w/hypoxia, Covid pneumonia, A-fib, and lactic acidosis. Intubated on 11/22. Tx'd w/dexamethasone, tocilizumab, inhaled epoprostenol. Remained severely hypoxic and expired 11/26/21.
no adverse event; Dose 1 received on 21-JAN-2021 and dose 2 received on 03-MAR-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 21-JAN-2021 and dose 2 received on 03-MAR-2021) and NO ADVERSE EVENT (no adverse event) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 21-JAN-2021 and dose 2 received on 03-MAR-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 21-JAN-2021 and dose 2 received on 03-MAR-2021) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 21-JAN-2021 and dose 2 received on 03-MAR-2021).    No concomitant medications were reported. On 16-MAR-2022, the patient received fourth dose of Pfizer . On 03-OCT-2022, the patient received fifth dose of Moderna COVID-19 vaccine bivalent of Lot number AS7162B. No treatment information was provided.
12 days after the vaccine I started with twitching in my right lower abdomen. Then 16 days after the vaccine I started with constant twitching in my right calf. Later that evening the twitching also began in the left calf. The next 2 days the twitching started all over my entire body. I have been having widespread muscle twitching all over my entire body since March 18th.
hives, it started on her hands and arms now is over legs, scalp is worst-- dry and itchy
Very mild sore arm; This is a spontaneous report from a contactable consumer or (patient).  A female patient of an unspecified age received bnt162b2 (BNT162B2), lot number not reported, via an unspecified route of administration from 17Jan2021 as SINGLE DOSE for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced very mild sore arm on an unspecified date with outcome of unknown.    Information about batch/lot number has been requested.
It was discovered that the pediatric vaccine was not diluted prior to administration resulting in a higher dose administered.  Adverse events are unknown, patient was not able to be reached. left message on 2/24/22 154pm
Erythema, warm to touch, and swollen at the site of injection: Started 06/05/2021 - Still occurring